Quick Answer
LIFECORE BIOMEDICAL, INC. \DE\ reported Total Assets of $239.34 million for fiscal year 2025.
LIFECORE BIOMEDICAL, INC. \DE\ Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $239.34M | -5.8% |
| 2024 | $253.96M | +0.2% |
| 2023 | $253.54M | +7.1% |
| 2023 | $236.66M | -14.2% |
| 2022 | $275.97M | +3.6% |
| 2022 | $266.38M | -3.0% |
| 2022 | $274.70M | -15.3% |
| 2022 | $324.24M | -23.0% |
| 2021 | $421.31M | -5.3% |
| 2021 | $444.73M | -11.4% |
| 2021 | $501.88M | -1.0% |
| 2021 | $506.86M | +1.8% |
| 2020 | $498.07M | -1.0% |
| 2020 | $503.04M | +71.4% |
| 2020 | $293.50M | -43.5% |
| 2019 | $519.09M | +28.3% |
| 2018 | $404.70M | +12.9% |
| 2017 | $358.61M | +4.7% |
| 2016 | $342.65M | -1.1% |
| 2015 | $346.46M | +10.5% |
| 2014 | $313.62M | +7.8% |
| 2013 | $290.94M | +4.8% |
| 2012 | $277.69M | +34.6% |
| 2011 | $206.31M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $235.20M | — | -1.7% |
| May 31, 2025 | $239.34M | -5.8% | +0.7% |
| February 28, 2025 | $237.69M | -3.5% | -6.9% |
| November 30, 2024 | $255.39M | +3.9% | +3.5% |
| August 31, 2024 | $246.82M | +0.5% | -2.8% |
| May 31, 2024 | $253.96M | +0.2% | +3.1% |
| February 29, 2024 | $246.24M | +4.3% | +0.2% |
| November 30, 2023 | $245.82M | -11.9% | +0.1% |
- LIFECORE BIOMEDICAL, INC. \DE\ showed a decrease of -5.8% in Total Assets compared to the prior fiscal year.
- Over the 2011–2025 period, LIFECORE BIOMEDICAL, INC. \DE\’s total assets has grown by 16.0% (from $206.31 million to $239.34 million).
- The most recent figure is from LIFECORE BIOMEDICAL, INC. \DE\’s fiscal year 2025 report (Form 10-K), filed with the SEC on August 7, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: